Human papillomaviruses and cervical cancer (Q41438690)

30 September 2017

1 reference

title

Human papillomaviruses and cervical cancer (English)

1 reference

30 September 2017

Villa LL

1

1 reference

30 September 2017

publication date

1 January 1997

1 reference

Advances in Cancer Research

30 September 2017

published in

1 reference

30 September 2017

volume

71

1 reference

30 September 2017

page(s)

321-341

1 reference

Nuclear factor I and epithelial cell-specific transcription of human papillomavirus type 16

30 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Possible prognostic significance of human papillomavirus type in cervical cancer

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Determinants of genital human papillomavirus infection in low-risk women in Portland, Oregon.

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Use of semi-quantitative PCR for human papillomavirus DNA type 16 to identify women with high grade cervical disease in a population presenting with a mildly dyskaryotic smear report.

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Sexually transmitted diseases and other risk factors for cervical dysplasia among southwestern Hispanic and non-Hispanic white women

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

The E6-E7 region of human papillomavirus type 18 is sufficient for transformation of NIH 3T3 and rat-1 cells

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Genome amplification of human papillomavirus types 16 and 18 in cervical carcinomas is related to the retention of E1/E2 genes.

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer.

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

The human papillomavirus type 16 E5 gene cooperates with the E7 gene to stimulate proliferation of primary cells and increases viral gene expression.

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Determinants of persistent detection of human papillomavirus DNA in the uterine cervix

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Low stringency-PCR (LS-PCR) allows entirely internally standardized DNA quantitation

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Analysis of genomic sequences of 95 papillomavirus types: uniting typing, phylogeny, and taxonomy

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Progesterone and glucocorticoid response elements occur in the long control regions of several human papillomaviruses involved in anogenital neoplasia

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Transcription of the transforming genes of the oncogenic human papillomavirus-16 is stimulated by tumor promotors through AP1 binding sites

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Vaccination of cattle with the N-terminus of L2 is necessary and sufficient for preventing infection by bovine papillomavirus-4.

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Human herpesvirus 6 infects cervical epithelial cells and transactivates human papillomavirus gene expression

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Divergent human papillomavirus type 16 variants are serologically cross-reactive.

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Transcriptional activation of human papillomavirus 16 by nuclear factor I, AP1, steroid receptors and a possibly novel transcription factor, PVF: a model for the composition of genital papillomavirus enhancers

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

The enhancer of human papillomavirus type 16: binding sites for the ubiquitous transcription factors oct-1, NFA, TEF-2, NF1, and AP-1 participate in epithelial cell-specific transcription

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Human papillomavirus type 16 cooperates with activated ras and fos oncogenes in the hormone-dependent transformation of primary mouse cells

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Characterization of a nuclear factor, papilloma enhancer binding factor-1, that binds the long control region of human papillomavirus type 16 and contributes to enhancer activity

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Human papillomavirus type 16 in cervical smears as predictor of high-grade cervical intraepithelial neoplasia [corrected]

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Type-specific human papillomavirus DNA in abnormal smears as a predictor of high-grade cervical intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Genetic heterogeneity among human papillomaviruses (HPV) associated with epidermodysplasia verruciformis: evidence for multiple allelic forms of HPV5 and HPV8 E6 genes

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Genetic heterogeneity of oncogenic human papillomavirus type 5 (HPV5) and phylogeny of HPV5 variants associated with epidermodysplasia verruciformis

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Transcriptional activation of several heterologous promoters by the E6 protein of human papillomavirus type 16

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Characterization of human keratinocytes transformed by high risk human papillomavirus types 16 or 18 and herpes simplex virus type 2.

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

HSV-2-induced tumorigenicity in HPV16-immortalized human genital keratinocytes

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Specific interaction between HPV-16 E1-E4 and cytokeratins results in collapse of the epithelial cell intermediate filament network

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Geographical dependence of sequence variation in the E7 gene of human papillomavirus type 16.

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Human papillomavirus infection is transient in young women: a population-based cohort study

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Viral etiology of cervical cancer: a critique of the evidence.

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Cancer Causes Revisited: Human Papillomavirus and Cervical Neoplasia

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Molecular Variant Analysis as an Epidemiological Tool to Study Persistence of Cervical Human Papillomavirus Infection

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Transmission of Cervical Human Papillomavirus Infection by Sexual Activity: Differences between Low and High Oncogenic Risk Types

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Navigating the descent into papillomavirus hell

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Interaction of HPV-18 and nitrosomethylurea in the induction of squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Prognostic importance of human papillomavirus type 16 DNA in cervical cancer

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Numerous nuclear proteins bind the long control region of human papillomavirus type 16: a subset of 6 of 23 DNase I-protected segments coincides with the location of the cell-type-specific enhancer.

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Genetic characterization of the human papillomavirus (HPV) 18 E2 gene in clinical specimens suggests the presence of a subtype with decreased oncogenic potential

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Variation of human papillomavirus type 6 (HPV-6) and HPV-11 genomes sampled throughout the world

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Increased age and mortality associated with cervical carcinomas negative for human papillomavirus RNA.

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Determinants of genital human papillomavirus infection in low-income women in Washington, D.C.

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Persistence of type-specific human papillomavirus infection among cytologically normal women

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Persistent Genital Human Papillomavirus Infection as a Risk Factor for Persistent Cervical Dysplasia

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Sequence variants of human papillomavirus type 16 from couples suggest sexual transmission with low infectivity and polyclonality in genital neoplasia

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

E6-AP directs the HPV E6-dependent inactivation of p53 and is representative of a family of structurally and functionally related proteins.

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Nucleotide and amino acid sequence variation in the L1 and E7 open reading frames of human papillomavirus type 6 and type 16

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16.

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Sequence rearrangements in the upstream regulatory region of human papillomavirus type 6: are these involved in malignant transition?

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Human papillomavirus, herpes simplex virus and other potential risk factors for cervical cancer in a high-risk area (Greenland) and a low-risk area (Denmark)--a second look.

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Transcriptional activation by the papillomavirus E6 zinc finger oncoprotein.

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Physical state and biological activity of human papillomavirus genomes in precancerous lesions of the female genital tract

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Determinants of genital human papillomavirus infection in young women

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Epidemiology and partial nucleotide sequence of four novel genital human papillomaviruses

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Human papillomavirus type 16 DNA cooperates with activated ras in transforming primary cells.

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Multiple human papillomavirus type 16 glucocorticoid response elements functional for transformation, transient expression, and DNA-protein interactions

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Estrogen and progesterone receptors in cervical human papillomavirus related lesions

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Natural history of cervical infection with human papillomaviruses

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Colposcopic and histologic findings and human papillomavirus (HPV) DNA test variability in young women positive for HPV DNA

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Antibodies to HPV-16 E6 and E7 proteins as markers for HPV-16-associated invasive cervical cancer

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

The role of HPV in the etiology of cervical cancer

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Clinical application of HPV typing in cervical cancer

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Serologic response to human papillomavirus type 16 (HPV-16) virus-like particles in HPV-16 DNA-positive invasive cervical cancer and cervical intraepithelial neoplasia grade III patients and controls from Colombia and Spain

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Identification of genomic sequences of three novel human papillomavirus sequences in cervical smears of Amazonian Indians

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Oncogenic transformation by human papillomavirus type 16 deoxyribonucleic acid in the presence of progesterone or progestins from oral contraceptives.

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

RU486 inhibits glucocorticoid hormone-dependent oncogenesis by human papillomavirus type 16 DNA.

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Glucocorticoid-dependent oncogenic transformation by type 16 but not type 11 human papilloma virus DNA.

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Identification of five novel human papillomavirus sequences in the New Mexico triethnic population

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Human papillomaviruses and genital cancer

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A.

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Strategies for global control of cervical cancer

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Association between poor prognosis in early-stage invasive cervical carcinomas and non-detection of HPV DNA

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Cutaneous and mucosal human papillomavirus E4 proteins form intermediate filament-like structures in epithelial cells

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

PCR-detected genital papillomavirus infection: prevalence and association with risk factors for cervical cancer

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Disruption of either the E1 or the E2 regulatory gene of human papillomavirus type 16 increases viral immortalization capacity

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Human papillomavirus deoxyribonucleic acid as a prognostic indicator in early-stage cervical cancer: a possible role for type 18

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Increased E6/E7 transcription in HPV 18-immortalized human keratinocytes results from inactivation of E2 and additional cellular events

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

New Epidemiology of Human Papillomavirus Infection and Cervical Neoplasia

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Human papillomavirus (HPV) type 18 E7 protein is a short-lived steroid-inducible phosphoprotein in HPV-transformed cell lines

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Toward objective quality assurance in cervical cytopathology. Correlation of cytopathologic diagnoses with detection of high-risk human papillomavirus types.

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Multiple interactions between cellular factors and the non-coding region of human papillomavirus type 16.

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Screening for cervical cancer: prospects for the future

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Definition of human papillomavirus type 16 DNA levels in low and high grade cervical lesions by a simple polymerase chain reaction technique

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Genomic Integrity and the Genetics of Cancer

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Human papillomavirus and disease-free survival in FIGO stage Ib cervical cancer

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Phylogenetic classification of human papillomaviruses: correlation with clinical manifestations

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Influence of chromosomal integration on glucocorticoid-regulated transcription of growth-stimulating papillomavirus genes E6 and E7 in cervical carcinoma cells

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Human papillomavirus in false negative archival cervical smears: implications for screening for cervical cancer

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Association of human papillomavirus types 16 and 18 E6 proteins with p53.

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Determinants of genital human papillomavirus infection among cytologically normal women attending the University of New Mexico student health center

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Differential disruption of genomic integrity and cell cycle regulation in normal human fibroblasts by the HPV oncoproteins.

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Sequence variation in the noncoding region of human papillomavirus type 16 detected by single-strand conformation polymorphism analysis.

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Analysis of Human Papillomavirus Type 16 Variants Indicates Establishment of Persistent Infection

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Malignant transformation of HPV 16-immortalized human endocervical cells by cigarette smoke condensate and characterization of multistage carcinogenesis

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Human papillomavirus type 16 DNA-induced malignant transformation of NIH 3T3 cells

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Identification of the nuclear localization signal of human papillomavirus type 16 L1 protein

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Human genital cancer: synergism between two virus infections or synergism between a virus infection and initiating events?

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Human papillomaviruses in the pathogenesis of anogenital cancer

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Roots and perspectives of contemporary papillomavirus research

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

Human papillomaviruses.

1 reference

https://api.crossref.org/works/10.1016/S0065-230X(08)60102-5

7 January 2021

10.1016/S0065-230X(08)60102-5

Identifiers

DOI

0 references

1 reference